Drug Shortage Report for NAPROSYN
| Report ID | 239149 |
| Drug Identification Number | 02162466 |
| Brand name | NAPROSYN |
| Common or Proper name | Naproxen sustained release tablets |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NAPROXEN |
| Strength(s) | 750MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100s |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-10-02 |
| Estimated end date | 2025-03-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-10-03 |
| Company comments | Delays in manufacturing |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-10-03 | English | Compare |
| v5 | 2024-10-02 | French | Compare |
| v4 | 2024-10-02 | English | Compare |
| v3 | 2024-10-02 | French | Compare |
| v2 | 2024-10-02 | English | Compare |
| v1 | 2024-10-02 | English | Compare |
Showing 1 to 6 of 6